Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Generics (2)
69 Articles Available
2
3
Can't find what you're looking for? Try our
advanced search
.
Opioids
Generic Suboxone Sublingual Film Launched
PAO-M03-19-NI-004
Generics
Roche Counters Generic Competition with New Cancer Treatments
PAO-M02-19-NI-022
Generics
Sandoz Inc. Launches Authorized Generic Version of Buprenorphine and Naloxone Sublingual Film
PR-M02-19-NI-045
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., On New Policy to Improve Access for Drugs that Face Inadequate Generic Competition
PR-M02-19-NI-039
Generics
Teva Announces Launch of ALYQ™ (Tadalafil Tablets USP), a Generic Version of ADCIRCA® in the United States
PR-M02-19-NI-014
FDA Approval
FDA Approves First Generic Version of Sabril to Help Treat Seizures in Adults and Pediatric Patients with Epilepsy
PR-M01-19-NI-057
Spin-off Business
Mallinckrodt Spins off its Generics Business
PAO-M12-18-NI-005-11
FDA Approval
Perrigo Announces Tentative FDA Approval for the First To file Generic Version Of Ultravate® Lotion 0.05%
PR-M11-18-NI-107
Patent
Perrigo Confirms Patent Challenge For Generic Version Of Kerydin®
PR-M11-18-NI-008
Generics
FDA Looking for Way to Facilitate Simultaneous Generic Approvals
PAO-M10-18-NI-027
Generics
Gilead Makes Move to Launch Early Generics
PAO-M10-18-NI-001
Generics
FDA Grants Profounda Inc. Competitive Generic Therapy (CGT) Designation for planned ANDA filing of Minocycline Hydrochloride Microspheres, 1 mg
PR-M10-18-NI-014
Regulatory
Competitive Generic Therapy: A New Patient-Centric FDA Pathway
PAP-Q3-18-NI-008
Generics
Mylan Launches Authorized Generic of Ampyra® Tablets
PR-M09-18-NI-089
Generics
FDA approves first generic version of EpiPen
PR-M09-18-NI-068
Annoucement
Novartis Unloads Sandoz US Components
PAO-M09-18-NI-011
Generics
Mylan Launches First Generic for Adcirca® Tablets
PR-M09-18-NI-021
Generics
FDA Approves First Generic Drug Under New Pathway Aimed at Enhancing Market Competition for Sole Source Drugs
PR-M08-18-NI-108
Generics
First Generic Version of Epipen Receives FDA Approval
PAO-M08-18-NI-024
Business
Perrigo to Divest Its Prescription Drug Business
PAO-M08-18-NI-015
Legal
Novartis Goes to Court Over Gilenya Generics
PAO-M07-18-NI-020
FDA Approval
Amneal Announces FDA Approval and Launch of Generic Potassium Chloride Oral Solution
PR-M07-18-NI-081
Drug Development
Appeals Board Rules in Favor of Novartis and its Multiple Sclerosis Drug Gilenya
PAO-M07-18-NI-014
Announcement
Court Ruling in Favor of Aquestive Therapeutics Enjoining Dr. Reddy's Laboratories from Launching its Generic Suboxone Product
PR-M07-18-NI-053
«
2
3
»